Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:        
Net loss   $ (15,213) $ (6,950)  
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation expense   3,733 1,815  
Royalty purchase agreement asset impairment $ 1,575 1,575    
Change in fair value of contingent consideration under RPAs, AAAs, and CPPAs   (75)    
Common stock contribution to 401(k)   123 85  
Amortization of intangible assets 224 449    
Depreciation   2 3  
Non-cash lease expense   97 84  
Change in fair value of equity securities   15 251  
Changes in assets and liabilities:        
Trade and other receivables, net   (900) 204  
Prepaid expenses and other assets   (97) (398)  
Accounts payable and accrued liabilities   (769) 582  
Income taxes payable     (91)  
Operating lease liabilities   (102) (96)  
Unearned revenue recognized under units-of-revenue method   (970) (815)  
Net cash used in operating activities   (12,132) (5,326)  
Cash flows from investing activities:        
Payments of consideration under RPAs, AAAs and CPPAs   (14,650) (5,000)  
Receipts under RPAs, AAAs and CPPAs   2,934    
Net cash used in investing activities   (11,716) (5,000)  
Cash flows from financing activities:        
Payment of preferred stock dividends   (2,736) (2,736)  
Proceeds from exercise of options and other share-based compensation   208 1,905  
Taxes paid related to net share settlement of equity awards   (5) (1,038)  
Net cash used in financing activities   (2,533) (1,869)  
Net decrease in cash, cash equivalents and restricted cash   (26,381) (12,195)  
Cash, cash equivalents and restricted cash at the beginning of the period   57,826 95,377 $ 95,377
Cash, cash equivalents and restricted cash at the end of the period 31,445 31,445 83,182 $ 57,826
Supplemental Cash Flow Information:        
Cash paid for taxes     95  
Right-of-use assets obtained in exchange for operating lease liabilities   85    
Non-cash investing and financing activities:        
Preferred stock dividend accrual $ 1,368 1,368 $ 1,368  
Estimated fair value of contingent consideration under the LadRx Agreements   $ 1,000